Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIDTS Study - Rivaroxaban for the treatment of symptomatic isolated distal deep vein thrombosis
2016-000958-36Phase 3Completed
- Sponsor
- Dipartimento di Medicina Clinica e Sperimentale
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rivaroxaban in deep vein thrombosis (DVT) (2 arms), sponsored by Dipartimento di Medicina Clinica e Sperimentale. Started Jun 2021; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2016-000958-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000958-36.